Product Code: SR112023A2200
Abstract
Market Overview:
The global cell analysis market size reached US$ 19.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 31.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.7% during 2023-2028.
Cell analysis refers to an umbrella term for a wide variety of technologies that are utilized to study genetic and phenotypical characteristics of a cell. Its objective is to gain insights into the mechanisms of cellular functionality that requires an understanding of the cellular components, such as the DNA, RNA, protein content and cellular metabolites. Cell analysis is typically done to understand population heterogeneity, identifying minority sub-populations of interest, as well as discovering unique characteristics of individual cells. It further aids in gene and protein identification, and epigenomics, as well as understanding the factors that underlie cell health, proliferation and death.
Cell analysis is utilized across academic and research laboratories, hospitals, and biotechnology and pharmaceutical, for studying stem cells, immunology, neurology, non-invasive prenatal diagnosis and in-vitro fertilization. Furthermore, the rising prevalence of chronic diseases, along with the development of advanced therapies for the treatment of cancer, are encouraging technological advancements in cell analysis. For instance, Fluidigm Corporation, a US-based company, announced the introduction of a REAP-seq (RNA expression and protein sequencing) that will help researchers to understand the mechanisms of cancer progression and immune response. The increasing investments by governments of several nations in extensive research and development (R&D) activities in the life science sector are acting as another major growth-inducing factor. Other factors, such as the rapid expansion of the biopharmaceutical and biotechnological companies and significant growth in the healthcare industry, are expected to further create a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell analysis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, analysis type, techniques and end-user.
Breakup by Product:
Flow Cytometry Products
qPCR Products
Cell Microarrays
Microscopes
Spectrophotometers
Cell Counters
HCS Systems
Others
Breakup by Analysis Type:
Cell Identification
Cell Viability
Cell Signaling Pathways/Signal Transduction
Cell Proliferation
Cell Counting and Quality Control
Cell Interaction
Target Identification and Validation
Single-Cell Analysis
Others
Breakup by Techniques:
Molecular Approaches
Image-Based Approaches
Breakup by End-User:
Pharmaceutical and Biotechnology Companies and CROs
Hospitals and Diagnostic Laboratories
Research Institutes
Cell Culture Collection Repositories
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, Thermo Fisher Scientific, etc.
Key Questions Answered in This Report
- 1. What was the size of the global cell analysis market in 2022?
- 2. What is the expected growth rate of the global cell analysis market during 2023-2028?
- 3. What are the key factors driving the global cell analysis market?
- 4. What has been the impact of COVID-19 on the global cell analysis market?
- 5. What is the breakup of the global cell analysis market based on the product?
- 6. What is the breakup of the global cell analysis market based on the analysis type?
- 7. What is the breakup of the global cell analysis market based on the techniques?
- 8. What is the breakup of the global cell analysis market based on the end-user?
- 9. What are the key regions in the global cell analysis market?
- 10. Who are the key players/companies in the global cell analysis market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Cell Analysis Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Flow Cytometry Products
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 qPCR Products
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Cell Microarrays
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Microscopes
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Spectrophotometers
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Cell Counters
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 HCS Systems
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Others
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
7 Market Breakup by Analysis Type
- 7.1 Cell Identification
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cell Viability
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Cell Signaling Pathways/Signal Transduction
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Cell Proliferation
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Cell Counting and Quality Control
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Cell Interaction
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Target Identification and Validation
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
- 7.8 Single-Cell Analysis
- 7.8.1 Market Trends
- 7.8.2 Market Forecast
- 7.9 Others
- 7.9.1 Market Trends
- 7.9.2 Market Forecast
8 Market Breakup by Techniques
- 8.1 Molecular Approaches
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Image-Based Approaches
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Pharmaceutical and Biotechnology Companies and CROs
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Hospitals and Diagnostic Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Cell Culture Collection Repositories
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Agilent Technologies Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 BD Biosciences
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Bio-RAD Laboratories Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Danaher Corporation
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Illumina Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Merck KGaA
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Miltenyi Biotec
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Olympus Corporation
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 PerkinElmer Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Promega Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Sysmex Corporation
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Thermo Fisher Scientific
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis